FGF21 and metabolic dysfunction-associated steatotic liver disease: To test this hypothesis, we performed bariatric surgery on obese rats, maintained the animals on a HFD, and assessed the clinical diagnostic criteria of NAFLD as well as cellular changes in FGF21.